These data showed that IGF1R signaling seems to support neuroblastoma cell survival and that Cbl/Cbl-b-knockdown cells were indeed slightly more sensitive toward IGF1R inhibition than control cells, displaying a lower OSI-906 IC50 value (Figure S3G). This evidence concerns the gene CBLB and neuroblastoma.